About
Small Molecules
Areas of Focus
Categories
Small Molecule PharmaceuticalNJ, NY, PA
Clinical Trials (6)
View allTotal Trials
6
As Lead Sponsor
6
As Collaborator
0
Total Enrollment
1,054
By Phase
PHASE3: 3PHASE2/PHASE3: 2PHASE1/PHASE2: 1
By Status
ACTIVE_NOT_RECRUITING: 3NOT_YET_RECRUITING: 1UNKNOWN: 1COMPLETED: 1
Clinical Trials Pipeline6 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
Today
Hover over trial bars to see details
Recent Trials
NCT07191912Lead Sponsor
Confirmatory Study of Govorestat in CMT-SORD
PHASE3Not yet recruiting
155 participants
Started: Oct 31, 2025 · Completed: Jan 31, 2029
NCT05397665Lead Sponsor
Pharmacodynamic EffIcacy and Clinical Benefit of AT 007 in Patients With Sorbitol Dehydrogenase (SORD) Deficiency
PHASE2/PHASE3Active, not recruiting
56 participants
Started: Jan 1, 2022 · Completed: Oct 31, 2026
NCT05418829Lead Sponsor
AT-007 in Adult Subjects With Classic Galactosemia (CG)
PHASE3Unknown
7 participants
Started: Oct 1, 2021 · Completed: Dec 31, 2022
NCT04902781Lead Sponsor
Clinical Benefit, Safety, PK and PD Study of AT-007 in Pediatric Subjects With Classic Galactosemia
PHASE2/PHASE3Active, not recruiting
47 participants
Started: Mar 20, 2021 · Completed: Dec 31, 2024
NCT04083339Lead Sponsor
Safety and Efficacy of AT-001 in Patients With Diabetic Cardiomyopathy
PHASE3Active, not recruiting
675 participants
Started: Sep 20, 2019 · Completed: Dec 31, 2025
Locations (1)
Headquarters
New York, NY, United States
Map
Loading map...